Medications

Prescription drug monitoring program mandates

States that require prescribers to register with and use prescription drug monitoring programs in most clinical circumstances saw notably fewer opioid prescriptions and reduced opioid-related hospital use by Medicaid patients ...

Medications

J&J verdict sends opioid makers a billion-dollar warning

The US pharmaceutical industry faces tens of billions of dollars in potential damage payments for fueling the opioid addiction crisis after Oklahoma won a $572 million judgment against drugmaker Johnson & Johnson.

Medications

OxyContin maker negotiating settlement worth a reported $12B

Purdue Pharma and the thousands of state and local governments suing the maker of OxyContin over the nation's deadly opioid crisis are negotiating a $10 billion to $12 billion settlement under which the Sackler family would ...

Medications

J&J faces possible $17 billion payout for pushing opioids

US drugmaker Johnson & Johnson faces a potential record $17 billion damages payout Monday when an Oklahoma judge rules whether its aggressive promotion of opioid painkillers was responsible for the state's addiction epidemic.

Medications

Q&A: Deadly opioid crisis sparks lawsuits across the US

The first judgment is expected Monday in a lawsuit from a state government seeking to hold a drug company accountable for a U.S. opioid crisis that has ripped apart lives and communities. More trials and legal settlements ...

page 37 from 40